|  | All factors assessed by fDM | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 |  | VD(%) | VI(%) | VNC(%) | Min ADC (10-5mm2/sec) | Max ADC (10-5mm2/sec) | RECIST (cm) | Volume reduction rate of enhanced lesion (%) | |||||||
 |  | > 12.4 | ≤ 12.4 | < 3.6 | ≥ 3.6 | < 74.6 | ≥ 74.6 | < 70 | ≥ 70 | < 368 | ≥ 368 | < 40.3 | ≥ 40.3 | < −21.1 | ≥ −21.1 |
Median time (M) | 19.3 | 10.3 | 11.2 | 12.1 | 15.3 | 11 | 14.3 | 9.1 | 11.2 | 12.1 | 14.2 | 10.8 | 15.1 | 9.7 | |
95% CI | 13.4- | 7.8- | 7.2- | 7.8- | 6.9- | 7.8- | 7.8- | 7.2- | 7.2- | 6.9- | 7.8- | 7.2- | 11.2- | 7.2- | |
(M) | 45.9** | 13.4** | 45.9 | 15.3 | 45.9 | 15.1 | 22.7** | 10.8** | 23.2 | 15.1 | 45.9 | 15.1 | 45.9 | 15.3 | |
p value | log-rank | 0.022* | 0.521 | 0.128 | 0.011* | 0.176 | 0.118 | 0.143 | |||||||
wilcoxon | 0.033* | 0.834 | 0.35 | 0.045* | 0.413 | 0.223 | 0.083 |